Clinical trial
Midodrine Use in the Recovery Phase of Septic Shock
NCT02990546 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Midodrine Use in the Recovery Phase of Septic Shock
- Lead sponsor
- University of Virginia
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- March 1, 2017
- Completion date
- May 2, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock